Compugen Ltd (CGEN)
2.57
+0.03
(+1.18%)
USD |
NASDAQ |
Mar 28, 16:00
2.60
+0.03
(+1.17%)
After-Hours: 20:00
Compugen Enterprise Value: 179.41M for March 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 28, 2024 | 179.41M |
March 27, 2024 | 176.72M |
March 26, 2024 | 173.14M |
March 25, 2024 | 175.83M |
March 22, 2024 | 185.67M |
March 21, 2024 | 188.36M |
March 20, 2024 | 190.15M |
March 19, 2024 | 180.30M |
March 18, 2024 | 188.36M |
March 15, 2024 | 193.73M |
March 14, 2024 | 189.26M |
March 13, 2024 | 200.89M |
March 12, 2024 | 200.00M |
March 11, 2024 | 198.21M |
March 08, 2024 | 212.53M |
March 07, 2024 | 186.57M |
March 06, 2024 | 178.51M |
March 05, 2024 | 177.62M |
March 04, 2024 | 213.43M |
March 01, 2024 | 185.67M |
February 29, 2024 | 180.30M |
February 28, 2024 | 179.41M |
February 27, 2024 | 186.57M |
February 26, 2024 | 178.51M |
February 23, 2024 | 158.82M |
Date | Value |
---|---|
February 22, 2024 | 157.03M |
February 21, 2024 | 163.29M |
February 20, 2024 | 164.19M |
February 16, 2024 | 163.48M |
February 15, 2024 | 156.35M |
February 14, 2024 | 154.56M |
February 13, 2024 | 143.85M |
February 12, 2024 | 157.24M |
February 09, 2024 | 140.28M |
February 08, 2024 | 140.28M |
February 07, 2024 | 136.71M |
February 06, 2024 | 150.10M |
February 05, 2024 | 149.21M |
February 02, 2024 | 151.88M |
February 01, 2024 | 165.27M |
January 31, 2024 | 164.38M |
January 30, 2024 | 178.66M |
January 29, 2024 | 166.16M |
January 26, 2024 | 146.53M |
January 25, 2024 | 137.61M |
January 24, 2024 | 116.19M |
January 23, 2024 | 116.19M |
January 22, 2024 | 115.30M |
January 19, 2024 | 122.44M |
January 18, 2024 | 121.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-38.55M
Minimum
Sep 29 2022
1.472B
Maximum
Aug 25 2020
347.28M
Average
197.74M
Median
Enterprise Value Benchmarks
Pluri Inc | 29.43M |
BioLine Rx Ltd | 47.91M |
XTL Biopharmaceuticals Ltd | 13.11M |
Can Fite Biofarma Ltd | 1.122M |
BiomX Inc | 11.08M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 9.713M |
Revenue (Quarterly) | 33.46M |
Total Expenses (Quarterly) | 15.48M |
EPS Diluted (Quarterly) | 0.12 |
Profit Margin (Quarterly) | 29.03% |
Earnings Yield | -8.17% |
Normalized Earnings Yield | -8.171 |